Post by Christoph Loeffler
Managing Director Accenture Song ASG Region (Austria, Switzerland, Germany), Industry Lead Health & Life Science
In this article, my colleagues and I share an excerpt of the initial findings from our ongoing research into the adoption of AI and in particular conversational AI in healthcare, and resulting benefits and consequences for patients, providers, payers and biopharma companies.
